Therapeutic efficacy of intermittent versus continuous phototherapy in term neonates with hyperbilirubinemia: A randomized controlled trial
Journal of Neonatal-Perinatal Medicine · 07.08.2026
DOI: 10.1177/19345798261475688 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Neonatal-Perinatal Medicine, online erschienen am 07.08.2026. Verfasst von D Kumar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Uttar Pradesh University of Medical Sciences, Etawah, India. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
Neonatal jaundice affects most newborns due to immature bilirubin metabolism. Phototherapy continues to be the cornerstone of treatment, having significantly reduced bilirubin-induced neurotoxicity. This study compares continuous and intermittent phototherapy in term neonates with non-hemolytic indirect hyperbilirubinemia to evaluate their relative therapeutic efficacy in achieving effective bilirubin reduction.
Methods
This prospective randomized controlled trial was conducted in the Neonatal Intensive Care Unit of a tertiary care medical university in North India between August 2023 and July 2025. Term neonates (gestational age 37–42 weeks, birth weight ≥2500 g) with non-hemolytic indirect hyperbilirubinemia requiring phototherapy, as per American Academy of Pediatrics guidelines, were enrolled. A total of 150 eligible infants were randomized in equal numbers to receive either continuous phototherapy or intermittent phototherapy (3 h on/3 h off). All participants received standardized double-surface LED phototherapy with an irradiance of ≥30 μW/cm 2 /nm within a wavelength range of 460–490 nm. Infants were repositioned hourly, and exclusive breastfeeding was actively supported. Total serum bilirubin levels were monitored at 12-h intervals until the predefined discontinuation criteria were met.
Results
Baseline characteristics were comparable (all p > 0.05). Mean baseline TSB was similar (16.07 ± 2.67 vs 15.46 ± 3.04 mg/dL; p = 0.190). Unadjusted bilirubin reduction at 12 h and 24 h did not differ significantly. After adjustment, TSB at 12 h was comparable ( p = 0.418), but higher in the continuous group at 24 h (mean difference 0.68 mg/dL; p < 0.001). The total phototherapy exposure time was shorter with intermittent therapy (13.75 ± 1.18 vs 18.15 ± 1.56 h; p = 0.001). Rebound hyperbilirubinemia and adverse events were similar between groups.
Conclusion
Intermittent phototherapy was as effective as continuous phototherapy in reducing bilirubin levels in term neonates with non-hemolytic indirect hyperbilirubinemia requiring treatment, while reducing total phototherapy exposure time and potentially facilitating feeding, mother–infant bonding, and more resource-efficient family-centered care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Uttar Pradesh University of Medical Sciences, Etawah, India.
- Department of Obstetrics and Gynaecology, Uttar Pradesh University of Medical Sciences, Etawah, India.
ORCID-Profile: D Kumar, D Kumar, R Chand, R Nivethaashree, S Singh, D Rastogi, D Sankhwar
Zitieren
APA
Kumar, D., Kumar, D., Chand, R., Nivethaashree, R., Singh, S., Rastogi, D., & Sankhwar, D. (2026). Therapeutic efficacy of intermittent versus continuous phototherapy in term neonates with hyperbilirubinemia: A randomized controlled trial. Journal of Neonatal-Perinatal Medicine. https://doi.org/10.1177/19345798261475688
Vancouver
Kumar D, Kumar D, Chand R, Nivethaashree R, Singh S, Rastogi D, et al. Therapeutic efficacy of intermittent versus continuous phototherapy in term neonates with hyperbilirubinemia: A randomized controlled trial. Journal of Neonatal-Perinatal Medicine. 2026. doi:10.1177/19345798261475688
BibTeX
@article{Kumar2026,
author = {Kumar, D and Kumar, D and Chand, R and Nivethaashree, R and Singh, S and Rastogi, D and Sankhwar, D},
title = {Therapeutic efficacy of intermittent versus continuous phototherapy in term neonates with hyperbilirubinemia: A randomized controlled trial},
journal = {Journal of Neonatal-Perinatal Medicine},
year = {2026},
doi = {10.1177/19345798261475688}
}
EUVIMED